Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Preface | p. ix |
Editors and Contributing Authors | p. xi |
Biology of Cardiovascular Disease | |
Coronary Artery Disease, Atherobiology, and Thrombosis | p. 3 |
Introduction | p. 3 |
Atherosclerotic Plaque Homeostasis | p. 3 |
Thrombosis Formation: Cellular and Molecular Mechanisms | p. 10 |
Plaque Regression: Emerging Therapies Leading to Plaque Regression | p. 18 |
Heart Failure: Role of Cardiac Imaging | p. 29 |
Introduction | p. 29 |
Imaging Modalities in Heart Failure | p. 33 |
Magnetic Resonance Imaging | p. 43 |
Nuclear Imaging | p. 47 |
Future Directions | p. 48 |
Conclusion | p. 49 |
Atrial Arryhthmias | p. 51 |
Introduction | p. 51 |
General Mechanisms of Atrial Arrhythmias | p. 51 |
Pathophysiology and Features of Atrial Arrhythmias | p. 54 |
Treatment of Atrial Arrhythmias | p. 67 |
Conclusion | p. 69 |
The Biology of Ventricular Dysrhythmias and Sudden Cardiac Death | p. 77 |
Introduction | p. 77 |
Arrhythmic Substrates | p. 78 |
Genetic Predisposition to Arrhythmias | p. 87 |
Conclusion | p. 87 |
The Biology of Congenital Heart Disease | p. 93 |
Introduction | p. 93 |
Incidence and Changing Trends | p. 93 |
Genetics and Recurrence Risk | p. 94 |
Residua and Sequelae | p. 95 |
Pregnancy | p. 98 |
Conclusion | p. 99 |
Imaging Technologies in Cardiovascular Disease | |
Echocardiography | p. 105 |
Introduction | p. 105 |
M-Mode Echocardiography | p. 106 |
Two-Dimensional Echocardiography | p. 106 |
Echo Imaging Modalities | p. 110 |
Imaging Techniques | p. 119 |
Specific Indications | p. 123 |
Assessment of Systolic LV Function | p. 124 |
Assessment of LV Diastolic Function/Filling Pressures | p. 126 |
Transthoracic Echocardiography in Specific Cardiac Conditions | p. 129 |
Aortic Valve | p. 131 |
Mitral Valve | p. 135 |
Tricuspid Valve | p. 139 |
Pulmonary Valve | p. 141 |
Dilated Cardiomyopathy | p. 142 |
Hypertrophic Cardiomyopathy | p. 143 |
Restrictive Cardiomyopathy | p. 145 |
Computerized Tomography | p. 159 |
Development of Cardiac CT Technology | p. 159 |
Coronary Calcium Screening | p. 161 |
Coronary CT Angiography | p. 163 |
Functional Imaging of the Heart by CT | p. 168 |
Challenges and Future Potentials of Cardiac CT | p. 169 |
Magnetic Resonance Imaging | p. 173 |
Introduction | p. 173 |
Pathobiology of Atherosclerosis | p. 173 |
Imaging Atherosclerosis | p. 175 |
Conclusions and Future Directions | p. 182 |
Nuclear Based Techniques | p. 189 |
Introduction | p. 189 |
Isotopes and Radiopharmaceuticals | p. 189 |
Cameras and Camera Design | p. 191 |
Applications of Stress Myocardial Perfusion Imaging and Selection of Candidates for Testing | p. 203 |
Testing for Special Indications | p. 206 |
Conclusion | p. 207 |
Novel Intravascular Imaging Technologies | p. 211 |
Introduction | p. 211 |
Histopathologic Vulnerable Plaque Definitions | p. 211 |
Imaging of Vulnerable Plaques | p. 212 |
Imaging of Coronary Stents | p. 226 |
Conclusion | p. 229 |
Imaging and Cardiovascular Research | |
Monitoring Regression and Progression of Atherosclerosis | p. 237 |
Introduction | p. 237 |
Modalities for Imaging Plaque Progression | p. 237 |
Lessons Learned from Medical Therapies | p. 242 |
Conclusion | p. 250 |
Use of Imaging in Research on Systolic and Diastolic Function | p. 257 |
Introduction | p. 257 |
Statistical Considerations | p. 257 |
Imaging Considerations | p. 258 |
Evaluation of LV Systolic Function | p. 258 |
Evaluation of LV Diastolic Function | p. 267 |
Conclusion | p. 270 |
Atrial Pathobiology and Electroanatomic Mapping for Research | p. 273 |
Introduction | p. 273 |
Remodeling Due to Atrial Arrhythmia and Structural Disease | p. 273 |
Site-Specific Conduction | p. 276 |
Electroanatomic Mapping in Research | p. 276 |
Conclusion | p. 288 |
Imaging in Clinical Management | |
Clinical Use of Imaging for Cardiovascular Risk Assessment | p. 293 |
Introduction | p. 293 |
The Need for Additional Risk Stratification | p. 293 |
The SHAPE Guideline Recommendations | p. 294 |
Criteria to Evaluate Improved Risk Stratification | p. 294 |
Coronary Artery Calcium Score | p. 295 |
Future Imaging Technologies | p. 301 |
Conclusion | p. 301 |
Chest Pain Evaluation | p. 307 |
Introduction | p. 307 |
Echocardiography | p. 307 |
Cardiovascular Magnetic Resonance | p. 310 |
Nuclear Medicine Techniques | p. 312 |
Computed Tomography | p. 314 |
Conclusion | p. 317 |
Evaluation of Dyspnea | p. 321 |
Introduction | p. 321 |
Investigating Dyspnea | p. 321 |
Nuclear Cardiology | p. 330 |
Cardiac Magnetic Resonance Imaging | p. 334 |
Computed Tomography | p. 341 |
Conclusion | p. 346 |
Congenital Heart Disease Assessment | p. 349 |
Introduction | p. 349 |
Echocardiography | p. 349 |
Cardiovascular Magnetic Resonance | p. 350 |
Anatomy Assessment in Congenital Heart Disease | p. 350 |
Function and Physiology Assessment in Congenital Heart Disease | p. 351 |
CMR Flow Assessment in Congenital Heart Disease | p. 351 |
Gadolinium-Enhanced MR Angiography | p. 351 |
Evaluation of Specific Congenital Heart Lesions | p. 352 |
Single Ventricle | p. 354 |
Aorta | p. 355 |
Conclusion | p. 356 |
Index | p. 359 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.